Recombinant multi-species DPP9/DPP-9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DPP9/DPP-9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that is a member of the S9B family in clan SC of the serine proteases. The protein has been shown to have post-proline dipeptidyl aminopeptidase activity, cleaving Xaa-Pro dipeptides from the N-termini of proteins. Although the activity of this protein is similar to that of dipeptidyl peptidase 4 (DPP4), it does not appear to be membrane bound. In general, dipeptidyl peptidases appear to be involved in the regulation of the activity of their substrates and have been linked to a variety of diseases including type 2 diabetes, obesity and cancer. Several transcript variants of this gene have been described but not fully characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 6430584G11Rik,A330078I11,DP9,DPLP9,DPP IX,DPP-9,DPP9,DPRP-2,DPRP2,Dipeptidyl peptidase 9,Dipeptidyl peptidase IV-related protein 2 (DPRP-2),Dipeptidyl peptidase IX (DPP IX),Dipeptidyl peptidase-like protein 9 (DPLP9),Dpp9,HATIS,IMD111

Target products collectionGo to DPP9/DPP-9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T66252-Ag-1/ GM-Tg-hg-T66252-Ag-2 Human DPP9/DPP-9 protein Human
GM-Tg-rg-T66252-Ag-1/ GM-Tg-rg-T66252-Ag-2 Rat DPP9/DPP-9 protein Rat
GM-Tg-mg-T66252-Ag-1/ GM-Tg-mg-T66252-Ag-2 Mouse DPP9/DPP-9 protein Mouse
GM-Tg-cynog-T66252-Ag-1/ GM-Tg-cynog-T66252-Ag-2 Cynomolgus/Rhesus macaque DPP9/DPP-9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T66252-Ag-1/ GM-Tg-felg-T66252-Ag-2 Feline DPP9/DPP-9 protein Feline
GM-Tg-cang-T66252-Ag-1/ GM-Tg-cang-T66252-Ag-2 Canine DPP9/DPP-9 protein Canine
GM-Tg-bovg-T66252-Ag-1/ GM-Tg-bovg-T66252-Ag-2 Bovine DPP9/DPP-9 protein Bovine
GM-Tg-equg-T66252-Ag-1/ GM-Tg-equg-T66252-Ag-2 Equine DPP9/DPP-9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T66252-Ag-1/ GM-Tg-hg-T66252-Ag-2; GM-Tg-rg-T66252-Ag-1/ GM-Tg-rg-T66252-Ag-2;
GM-Tg-mg-T66252-Ag-1/ GM-Tg-mg-T66252-Ag-2; GM-Tg-cynog-T66252-Ag-1/ GM-Tg-cynog-T66252-Ag-2;
GM-Tg-felg-T66252-Ag-1/ GM-Tg-felg-T66252-Ag-2; GM-Tg-cang-T66252-Ag-1/ GM-Tg-cang-T66252-Ag-2;
GM-Tg-bovg-T66252-Ag-1/ GM-Tg-bovg-T66252-Ag-2; GM-Tg-equg-T66252-Ag-1/ GM-Tg-equg-T66252-Ag-2
Products Name DPP9/DPP-9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DPP9/DPP-9
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DPP9/DPP-9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.